Photobiomodulation for Breast Cancer Radiodermatitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Breast CancerRadiodermatitisRadiotherapy Side EffectRadiation DermatitisRadiation ToxicityRadiation InjuriesQuality of LifeBreast Neoplasms
Interventions
DEVICE

Photobiomodulation

Photobiomodulation will be with the Cicatrillux (Cosmedical®) LED that contains 36 red light emitters in a 10x12 cm neoprene plate with 650 nm LED wave length whose optical spot diameter is 5 mm and with an average wave length of 2 \~ 5 mw for 10 minutes that will be placed over the area that will be irradiated for 10 minutes;

Trial Locations (1)

Unknown

Universidade do Vale do Itajai - UNIVALI, Itajaí

All Listed Sponsors
lead

AC Camargo Cancer Center

OTHER

NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis | Biotech Hunter | Biotech Hunter